NOD2 Muramyl Dipeptide Sensing
NOD2 muramyl dipeptide sensing operates as a vital cytosolic pattern-recognition mechanism, recognizing bacterial peptidoglycan fragments to initiate pro-inflammatory immune responses.
NOD2 muramyl dipeptide sensing is a primary intracellular pattern-recognition mechanism of the mammalian innate immune system responsible for detecting fragments of bacterial cell walls within the host cytoplasm. Nucleotide-binding oligomerization domain-containing protein 2 (NOD2), encoded by the CARD15 gene, belongs to the cytosolic NLR (nucleotide-binding domain and leucine-rich repeat containing) receptor family. NOD2 functions as a biosensor that detects muramyl dipeptide (MDP), the minimal bioactive motif conserved across both Gram-positive and Gram-negative bacterial peptidoglycans.
Upon recognizing cytosolic MDP, NOD2 undergoes a conformational change that promotes oligomerization, recruiting the downstream kinase RIPK2 and coordinating pro-inflammatory NF-ฮบB and MAP kinase cascades to clear intracellular microbes and regulate mucosal homeostasis.
Molecular Architecture of the NOD2 Receptor
NOD2 is a multidomain protein consisting of three distinct functional modules arranged from amino to carboxyl terminus:
- N-terminal Effector Domain: Composed of two tandem Caspase Activation and Recruitment Domains (CARDs), which mediate homotypic protein-protein interactions with downstream signaling adaptors.
- Central Nucleotide-Binding Domain (NBD/NACHT): Facilitates dNTPase activity and self-oligomerization, serving as the molecular switch that governs receptor activation.
- C-terminal Leucine-Rich Repeat (LRR) Domain: Composed of 28 leucine-rich motifs organized into a curved horseshoe structure that mediates ligand recognition and auto-inhibition in the resting state.
In the basal, unstimulated state, NOD2 resides in an auto-inhibited monomeric conformation in which the C-terminal LRR folds over the NACHT domain, sterically occluding the nucleotide-binding pocket and preventing spontaneous oligomerization.
Ligand Specificity and Intracellular Delivery of MDP
The minimal cognate ligand for NOD2 is muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine), a biochemical constituent of bacterial peptidoglycan. Peptidoglycan forms a mesh-like layer outside the plasma membrane of nearly all eubacteria, alternating N-acetylglucosamine and N-acetylmuramic acid residues cross-linked by short peptides.
Unlike extracellular or endosomal Toll-like receptors (such as TLR2 or TLR4), NOD2 monitors the interior of the host cell. Because intact bacteria or large peptidoglycan polymers cannot freely penetrate the eukaryotic plasma membrane, delivery of MDP to cytosolic NOD2 requires specialized entry mechanisms:
- Bacterial Invasion and Secretion: Intracellular pathogens (such as Listeria monocytogenes or Shigella flexneri) actively shed peptidoglycan fragments directly into the host cytoplasm during replication or via specialized type III or type IV secretion systems.
- Endosomal Transporters: Extracellular or phagocytosed peptidoglycan fragments are internalized via endocytosis and transported into the cytosol through solute carrier proteins, notably SLC15A1 (PEPT1) and SLC15A2 (PEPT2).
- Outer Membrane Vesicles: Gram-negative bacteria release outer membrane vesicles (OMVs) containing peptidoglycan that enter non-phagocytic epithelial cells through endocytosis, subsequently releasing MDP into the cytoplasmic compartment.
Upon entering the cytosol, MDP binds with nanomolar affinity to the LRR domain of NOD2, inducing an ATP-dependent conformational change that releases the auto-inhibitory fold.
Signal Transduction Cascade: RIPK2 Oligomerization and NF-ฮบB Activation
Once liberated from auto-inhibition by ligand engagement, the central NACHT domains of multiple NOD2 monomers bind ATP and assemble into a high-order oligomeric signaling platform within the eukaryotic cytoplasm. This oligomerization event exposes the tandem N-terminal CARD effector domains, initiating a highly coordinated signal transduction cascade that coordinates both transcriptional and post-translational immune defenses.
RIPK2 Recruitment and Polyubiquitination
The exposed tandem CARD domains of oligomerized NOD2 interact homotypically with the single CARD domain of the serine/threonine protein kinase RIPK2 (receptor-interacting serine/threonine-protein kinase 2, also known as RICK). This interaction forms a filamentous protein complex termed the "nodosome."
Recruitment to the nodosome activates RIPK2 and facilitates its extensive non-degradative polyubiquitination. E3 ubiquitin ligases, including cIAP1, cIAP2, and XIAP, conjugate K63-linked and linear (M1-linked) polyubiquitin chains onto lysine residues of RIPK2.
Downstream Kinase Activation
These polyubiquitin chains serve as high-affinity docking scaffolds for downstream signaling complexes:
- TAK1 Complex: The TAB1/TAB2/TAK1 kinase complex binds K63-linked ubiquitin chains, activating the kinase TAK1 (MAP3K7).
- LUBAC and IKK Complex: Linear ubiquitin chains recruit the IฮบB kinase (IKK) complex, composed of catalytic subunits IKKฮฑ and IKKฮฒ, alongside the regulatory scaffold NEMO (IKKฮณ).
TAK1 directly phosphorylates and activates IKKฮฒ within the IKK complex. In turn, activated IKKฮฒ phosphorylates IฮบBฮฑ, the cytoplasmic inhibitor of NF-ฮบB. Phosphorylated IฮบBฮฑ undergoes K48-linked polyubiquitination and rapid degradation by the 26S proteasome, freeing NF-ฮบB dimers (p50/p65) to translocate into the nucleus. Simultaneously, TAK1 activates the MAPK pathways (p38, JNK, and ERK), amplifying transcription of inflammatory cytokines, chemokines (such as CXCL8), and antimicrobial peptides (including alpha- and beta-defensins).
Clinical Genetics and Crohn's Disease Pathogenesis
The physiological importance of NOD2 sensing was demonstrated in 2001 when genetic linkage studies identified strong associations between polymorphisms in NOD2 (CARD15) and susceptibility to Crohn's disease, a chronic inflammatory bowel disease.
Three primary single-nucleotide variants account for the majority of disease-associated mutations:
- R702W: Located in the boundary between the NACHT and LRR domains.
- G908R: Situated within the LRR binding pocket.
- 1007fs: A frameshift mutation resulting in truncation of the terminal 33 amino acids of the LRR domain.
All three major Crohn's-associated mutations result in loss-of-function phenotypes regarding MDP sensing: mutant NOD2 proteins fail to recognize muramyl dipeptide or initiate downstream NF-ฮบB activation. In intestinal Paneth cells, impaired NOD2 sensing diminishes the baseline secretion of antimicrobial alpha-defensins (HD-5 and HD-6). This defect compromises the mucosal antibacterial barrier, permitting persistent colonization by commensal and pathobiont bacteria, which triggers secondary chronic inflammation through compensatory adaptive immune mechanisms.
Therapeutic Targeting and Pharmacological Modulators
Due to its pivotal role in mucosal immunity and chronic inflammation, the NOD2 signaling axis is an active target for pharmacological intervention. Small-molecule RIPK2 inhibitors prevent kinase activation and scaffolding functions, showing promise in preclinical models of autoimmune colitis and arthritis. Conversely, synthetic NOD2 agonists are under investigation as vaccine adjuvants, utilizing the natural potency of MDP analogs to stimulate targeted cellular immunity without inducing systemic toxicity.
References
- Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., ... & Sansonetti, P. J. (2003). Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. Journal of Biological Chemistry, 278(11), 8869-8872. https://doi.org/10.1074/jbc.C200651200
- Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., ... & Nunez, G. (2003). Host recognition of bacterial muramyl dipeptide mediated through NOD2. Journal of Biological Chemistry, 278(8), 5509-5512. https://doi.org/10.1074/jbc.C200673200
- Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J. P., Belaiche, J., ... & Thomas, G. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature, 411(6837), 599-603. https://doi.org/10.1038/35079107